Office of Grant Writing & Publications.

Damon Runyon Cancer Research Foundation Clinical Investigator Award

Office of Grant Writing & Publications

202 Jesse Hall
University of Missouri
Columbia, MO 65211

573 882-9500 phone
573 884-8371 fax

Limited Submission Announcement

The Damon Runyon Cancer Research Foundation Clinical Investigator Award supports early career physician-scientists conducting patient-oriented research. The goal of this innovative program is to increase the number of physicians capable of moving seamlessly between the laboratory and the patient’s bedside in search of breakthrough treatments. The Clinical Investigator Award program is specifically intended to provide outstanding young physicians with the resources and training structure essential to becoming independent clinical investigators.

The Clinical Investigator Award responds to three recognized realities:

  1. Though there has never been a more pressing need or more promising time for clinical cancer research, fewer young physicians enter this area of investigation every year.
  2. The number of institutions committed to training young physicians in the scientific discipline and methodologies of clinical investigation is critically low.
  3. The burden of medical school debt (averaging over $100,000) discourages many physicians from pursuing clinical investigation.


  • The applicant must be a U.S. citizen or permanent legal resident.
  • Each applicant must be nominated by his/her institution.
  • The applicant must have received an MD or MD/PhD degree(s) from an accredited institution and be board-eligible.
  • The applicant may apply during the final year of his/her subspecialty training or within the first four years of his/her initial assistant professorship appointment (cut-off July 1, 2006).
  • The applicant must hold or be in the process of securing a tenure-track position at his/her institution.
  • Candidates may apply up to three times during this eligibility period. Candidates holding or awarded R01s at the time of application are not eligible to apply.
  • The applicant must commit to spending 80% of their time conducting research.
  • The applicant is required to apply in conjunction with a Mentor who is established in the field of clinical translational cancer research, cancer prevention and/or epidemiology and can provide the critical guidance needed during the period of the award. No more than two Damon Runyon Clinical Investigators will be funded to work with the same Mentor at any given time.

Because MU is limited to three applications for this program, letters of intent must be submitted to the Office of Research,, no later than 4:00 p.m. on Friday, January 15, 2010. Letters of intent should be limited to a 2-page biographical sketch for the nominee and a 2-page summary of the following: 1) proposed research project, its significance to the field of cancer and/or cancer prevention, and its adherence to the definition of clinical research; and 2) the mentor and proposed training plan.


The $450,000 award will be for a period of three years. Annually, funding of $150,000 ($100,000 stipend and $50,000 research allowance) will be allocated to the awardee’s institution for the specific support of the Clinical Investigator. A portion of the stipend may be applied to research costs upon request. No part of this award can be used for indirect costs or institutional overhead. The Foundation will also retire up to $100,000 of any medical school debt still owed by the awardee.

MU Deadline:

4:00 p.m., Friday, January 15, 2010

Sponsor Deadline:

March 1, 2010


URL for more information:

All limited submission announcements can be tracked by deadline via the Calendar at or by announcement date via the Limited Submissions listing at